Labcorp narrows FY24 adjusted EPS view to $14.45-$15.35 from $14.30-$15.40

Consensus $14.82. The company said, “Labcorp is updating 2024 full year guidance to reflect its first quarter performance and full year outlook. The following guidance assumes foreign exchange rates effective as of March 31, 2024, for the remainder of the year. Enterprise level guidance includes the estimated impact from currently anticipated capital allocation, including acquisitions, share repurchases and dividends.”